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A report on the 2006 Keystone Conference on Signaling
Networks, Vancouver, Canada, 30 January-4 February 2006.
The boundaries between traditional notions of cellular signal-
ing and more genomic and systematic approaches to biology
are becoming increasingly blurred, and the recent Keystone
conference on signaling networks reflected an expanded view
of signaling. It is becoming increasingly accepted that genes,
proteins, cells, and organisms function as components of
larger systems, rather than independent activities contributing
to a single defined outcome, and many presentations at the
conference reflected this. If there was a single theme, it was
the heavy reliance on technical approaches in functional
genomics, proteomics, and computational biology, such that
conceptual and technical discussions often dominated the
resulting biology. 
RNA interference screening
The impact of technology on the study of signaling networks
was most evident in the widespread application of RNA
interference (RNAi) screens. Screens to study signaling net-
works in multicellular organisms using RNAi technology are
being performed with success, although several hurdles
clearly remain. One of these is the apparently high rate of
false positives. In his keynote lecture, Norbert Perrimon
(Harvard Medical School, Boston, USA) predicted an
uncomfortably high rate of false positives due to off-target
effects, at least in Drosophila. Consistent with this, Phil
Beachy (Johns Hopkins University School of Medicine, Bal-
timore, USA) described an ongoing RNAi screen in
Drosophila looking for proteins involved in the Wingless sig-
naling pathway. Following efforts to study a previously
uncharacterized gene identified by this screen, it was noted
that there were 16 bases in the interfering RNA that were
identical to armadillo, a known gene in the pathway, sug-
gesting that it is an unanticipated off-target that could com-
pletely explain the phenotype conferred by the interfering
RNA. Perrimon proposed that incorporating other types of
data, such as protein-protein interaction information, can
help decipher which hits are physiologically relevant. Rene
Bernards (Netherlands Cancer Institute, Amsterdam, The
Netherlands) commented that reporting lists of unconfirmed
hits from genome-wide RNAi screens in humans might be
detrimental to future work by creating distractions from
more productive lines of research, and that scientists (and
journals) perhaps need to be more mindful of this.
Despite these limitations, work presented on Caenorhabditis
elegans showed unquestionably that useful biological infor-
mation could be extracted from RNAi screens. Gary Ruvkun
(Massachusetts General Hospital, Boston, USA) and col-
leagues have been involved in a variety of screens looking for
factors involved in lifespan, molting, defects in fat storage,
and the RNAi pathway itself. Ruvkun described the complete
list of hits from the molting screen as a “rogues’ gallery” of
phenotypes and molecular functions. One could argue that
this might be evidence not so much of a high false-positive
rate as of the dependence of a system on many components
and processes; a corollary of this is that perturbation of an
individual gene can have a myriad of physiological effects.
Andrew Fraser (Wellcome Trust Sanger Institute, Cam-
bridge, UK) presented work that supports this view. His
group has been performing synthetic interaction screens in
C. elegans in which previously characterized worm mutants
defective in the epidermal growth factor (EGF)-Ras-Raf-
MAP kinase pathway are treated with libraries encoding
double-stranded RNAs, in order to identify synthetic genetic
interactions. A significant outcome of this work was that
RNAi of genes in certain functional categories results in syn-
thetic effects with a high proportion of all mutants tested,suggesting that some cellular functions buffer or canalize
many physiological traits, rather than perform a single
physiological function.
David Sabatini (Massachusetts Institute of Technology,
Cambridge, USA) presented a thorough overview of techni-
cal aspects of the development and use of genome-scale
lentiviral RNAi libraries for human and mouse. A consor-
tium of groups in the public and private sectors is contribut-
ing to the creation of the libraries, which are sold by both
Sigma (St. Louis, USA) and Open Biosystems (Huntsville,
USA) and are available as glycerol stocks, plasmids and
viruses. Sabatini commented that while this effort is still
incomplete, some functional categories (for example, tran-
scription factors) are fairly comprehensively covered. The
efficacy of the system has been validated by targeting tyrosine
kinases, and Sabatini reported that 90% of these genes have
at least one target that results in a significant knockdown of
expression. Sabatini also discussed issues of high-content
screening, such as image archiving (a screen can generate 1
Tb of images), image analysis, and defining a ‘hit’. He
described Cell Profiler [http://jura.wi.mit.edu/cellprofiler/],
a free, open-source software package for analysis of thou-
sands of cell images, which among other statistics can output
cell counts, DNA content and mitotic index. 
Sabatini gave his view on how to define true positives: as a
rule of thumb, he suggested requiring two independent hair-
pins that work (the consortium library contains several for each
gene), dose dependence, and complementation if possible.
Finally, he noted that as antibodies are not available for the
majority of human proteins, it is currently difficult to ascertain
whether protein levels are impacted by RNAi. On a similar
theme, Sumit Chanda (Genomic Institute of the Novartis
Research Foundation, San Diego, USA) pointed out that 50% of
work published in humans corresponds to less than 10% of the
genome, with few (or no) publications for most known and pre-
dicted genes, which provides a justification for comprehensive
screening efforts.
Chemical screening 
Chemicals have long been used to perturb specific biological
activities in experiments, and they have a particular appeal
because of their potential application as drugs. Justin Lamb
(Broad Institute, Cambridge, USA) described an ongoing
effort to construct a transcriptional connectivity map for bio-
medical discovery, which relates microarray gene-expression
profiles that are due to drug effects, disease, and gene per-
turbations. An initial goal is to find off-target uses for exist-
ing drugs; Lamb’s group is currently analyzing 1,500 drugs
approved by the US Food and Drug Administration (FDA),
500 non-drug bioactive compounds used as research tools,
and the effects of the knockdown of 500 potential drug
targets using lentivirally delivered short hairpin RNAs
(shRNAs). A distinguishing feature of the connectivity map
is the use of the Kalmogorov-Smirnov statistic to score a
relationship between two experiments, even in the absence of
an overall correlation. Lamb presented evidence from these
analyses to indicate that connections can be drawn between
drugs and diseases even if the experiments are performed in
different cell types, or possibly even different organisms,
which is significant because large-scale RNAi screens are typ-
ically performed in well behaved cultured cells.
An alternative assay for chemical activities was presented by
Soren Jensby Nielsen (BioImage, Soeborg, Denmark), who
described screening compounds for their impact on protein
translocation. He reported the effects of around 50 com-
pounds on the localization of a dozen different green fluores-
cent protein (GFP) fusion proteins. A surprising number of
effects were observed, and although effects appear to be
protein-specific (that is, they do not correlate with growth
inhibition or other general effects), Nielsen stated that this
screening approach has not yet identified any primary
targets, indicating that the observed mislocalizations are
probably downstream effects of perturbing the primary
target. Nevertheless, this is an intriguing approach to
screening, especially as it requires only a relatively basic
setup compared with high-content assays.
Protein-interaction networks 
Giulio Superti-Furga (CeMM Center for Molecular Medicine,
Vienna, Austria) and one of us (N.K.) both described efforts to
purify protein complexes for the entire proteome of Saccha-
romyces cerevisiae. The two groups used a similar strategy
involving the immunoprecipitation of affinity-tagged proteins
followed by mass spectrometry. Although proteomic studies
have been previously published in budding yeast, the current
studies attempt to tag and purify approximately 10 times as
many unique proteins than any previous study. Both studies
have just been published and comparison of the datasets with
each other and with others previously generated should allow
the compilation of the most comprehensive protein-interac-
tion map ever generated for an organism. 
A next goal will be to define similar physical interaction
maps in higher organisms. Marc Vidal (Dana-Farber Cancer
Institute, Boston, USA) presented work on uncovering inter-
acting proteins in human, focusing on two-hybrid analyses
that are then confirmed by pulldowns. Like Perrimon, Vidal
was enthusiastic about weighting the significance of interac-
tions on the basis of multiple independent data types, most
notably phenotypic profiles. 
Pathways and networks 
The term signaling pathway implies a cause-and-effect
relationship among a series of steps. Two talks concerned
the development of computational methods for the infer-
ence of cause and effect, or for determining the importance
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phenotypic analysis. Eric Schadt (Rosetta Inpharmatics,
Seattle, USA) pointed out that in genetic crosses information
can only flow from genotype to phenotype. In contrast, gene-
expression patterns can be either a cause or an effect of phe-
notypes. He gave a conceptual overview of the statistical
approaches his group is using to distinguish whether gene-
expression phenotypes are upstream or downstream of other
phenotypes in large mouse crosses. In summary, one can ask
which network structure is most consistent with the
observed correlations, with quantitative trait loci used as an
anchor. Alon Kaufman (Hebrew University, Jerusalem,
Israel) presented algorithms for calculating the contribution
of genes to a function that has been quantified via set of mul-
tiple mutants in factors that influence that function. These
algorithms, known as the ‘multi-perturbation shapely value
analysis’ and the ‘functional influence network’ algorithms,
can recreate some features of known networks and should
aid in predicting aspects of unknown pathways. 
Analysis of the consequences of multiple perturbations has
historically been a primary approach to dissecting genetic
and signaling networks. On the other hand, these computa-
tional analyses require a collection of quantitative genetic
data. Two talks described methods for generating such data
on a large scale in budding yeast. Jef Boeke (Johns Hopkins
University, Baltimore, USA) described a comprehensive
genetic analysis of approximately 70 genes involved in DNA
integrity. Analysis of the genetic patterns enables the estab-
lishment of ‘congruence groups’, functionally related clusters
that share the same pattern of synthetic sick or lethal (SSL)
interactions, but may not participate in synthetic sick or
lethal relationships among themselves. One of us (N.K.)
described the generation of an epistatic miniarray profile (a
quantitative analysis of double-mutant growth phenotypes
among a logically-selected subset of genes) of approximately
850 genes involved in most aspects of chromosome function.
This analysis detected not only synthetic sick or lethal inter-
actions, but also cases in which double deletions grow better
than would be expected from the growth of each single
mutant when crossed to most other mutants on the array.
The genes involved in these latter interactions often displayed
similar sets of genetic profiles and correlated well with physi-
cal interactions. Will RNAi enable the generation of such net-
works in higher organisms? Perhaps to some degree; however,
in the question-and-answer period, Fraser suggested that his
group had encountered a high false-negative rate in RNAi x
RNAi ‘crosses’ in C. elegans, relative to RNAi x germline
mutation, presumably because most RNAi knockdowns are
incomplete. 
Biological networks tend to have distinctive mathematical
properties, most notably a scale-free degree distribution,
the cause of which has been debated extensively. Ravi
Iyengar (Mount Sinai Medical Center, New York, USA) and
Albert-Laszlo Barabasi (University of Notre Dame, South
Bend, USA) both presented arguments and modeling results
supporting the notion that the origin of scale-free network
structures is likely to be a consequence of selection pressure
following gene duplication. Briefly, the idea is that newly
duplicated genes have increased chances of survival if they
develop a function that is tied to that of a gene that is already
functionally coupled to many other genes, creating a ‘rich get
richer’ scenario. The results of simulations of this paradigm
appear to match experimentally derived network structures.
In contrast to all the network technology, a biological high-
light was the description by Cori Bargmann (Rockefeller
University, New York, USA) of her lab’s demonstration that
C. elegans can learn to smell which bacteria it should and
should not eat, using a network of only a few hundred
neurons. Overall, the conference successfully integrated a
broad range of biological topics, including novel technolo-
gies and computational strategies that biologists can apply to
obtain meaningful systems-level biological information on
signaling networks. 
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